NCT05163912 is a NA clinical trial of Virtual home intervention in Type 1 Diabetes, sponsored by Yale University.

Who is sponsoring NCT05163912?

NCT05163912 is sponsored by Yale University.

What drugs are being tested in NCT05163912?

Interventions in NCT05163912: Virtual home intervention.

What condition does NCT05163912 study?

NCT05163912 studies Type 1 Diabetes.

Is NCT05163912 still recruiting?

NCT05163912 is currently completed. Last updated 27 August 2024.

Last reviewed 2024-08-27 · How we verify

NCT05163912

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Virtual Physical Activity for Type 1 Diabetes

Completed NA Last updated 27 August 2024

What this trial tests

NA trial testing Virtual home intervention in Type 1 Diabetes in 15 participants. Completed in 5 August 2022.

Timeline

4 January 2022

Primary endpoint
5 August 2022

5 August 2022

Quick facts

Lead sponsor	Yale University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	15
Start date	4 January 2022
Primary completion	5 August 2022
Estimated completion	5 August 2022
Sites	2 locations across United States

Drugs / interventions tested

Virtual home intervention

Conditions studied

Type 1 Diabetes — all drugs for Type 1 Diabetes →

Sponsor

Yale University

Who can join

Adults 14 to 19, any sex, with Type 1 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A virtual group of teens with type 1 diabetes, led by young adults with type 1 diabetes, will play active videogames and discuss activity and health. This study will evaluate the program for feasibility and user satisfaction.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

An Exergames Program for Adolescents With Type 1 Diabetes: Qualitative Study of Acceptability.
Mak SS, Nally LM, Montoya J, Marrero R, et al · · 2025 · cited 3× · PMID 40238214 · DOI 10.2196/65665
Testing Multiple Delivery Methods of the Virtual Exercise Games for Youth with T1D Peer Intervention: Protocol Development and Feasibility.
Ash GI, Nam S, Mak SS, Stults-Kolehmainen M, et al · · 2026 · PMID 41697894 · DOI 10.1159/000550880

Verify or expand the search:

Other recruiting trials for Type 1 Diabetes

Currently open trials in the same condition.

NCT07061574 — A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New On · Phase 1, PHASE2 · recruiting
NCT07360080 — Long-Term Outcomes of Teplizumab in Routine Clinical Care · recruiting
NCT07457580 — Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs) · recruiting
NCT07212179 — Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 · NA · recruiting
NCT07287943 — To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes. · NA · recruiting

Other Yale University trials

Trials by the same sponsor.

NCT06900998 — Pilot Study: Effects of Nimodipine on Alcohol Drinking · Phase 2 · not yet recruiting
NCT04910984 — Developing a Chatbot to Promote HIV Testing · NA · not yet recruiting
NCT07458087 — Accuracy of the Accuro 3S · NA · not yet recruiting
NCT07398404 — A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Pa · Phase 1, PHASE2 · not yet recruiting
NCT07305324 — Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05163912 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yale University
Last refreshed: 27 August 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05163912.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing